Your browser doesn't support javascript.
loading
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
Tsai, Shih-Tzu; Cho, Hong-Jun; Cheng, Huey-Shinn; Kim, Cheol-Hwan; Hsueh, Kuang-Chieh; Billing, Clare B; Williams, Kathryn E.
Affiliation
  • Tsai ST; Department of Community Medicine, Buddhist Tzu Chi General Hospital and Tzu Chi University College of Medicine, Hualien, Taiwan.
Clin Ther ; 29(6): 1027-39, 2007 Jun.
Article in En | MEDLINE | ID: mdl-17692719
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinoxalines / Benzazepines / Receptors, Nicotinic / Smoking Cessation / Nicotinic Agonists / Asian People Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Clin Ther Year: 2007 Document type: Article Affiliation country: Taiwán Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinoxalines / Benzazepines / Receptors, Nicotinic / Smoking Cessation / Nicotinic Agonists / Asian People Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Clin Ther Year: 2007 Document type: Article Affiliation country: Taiwán Country of publication: Estados Unidos